Randal Eckert
About Randal Eckert
Randal Eckert is the Associate Director of Research Project Management at Bristol Myers Squibb in Seattle, Washington, with extensive experience in nonclinical development and preclinical biology.
Company
Randal Eckert is currently working at Bristol Myers Squibb as an Associate Director of Research Project Management. The company is located in Seattle, Washington, United States. His role at Bristol Myers Squibb involves managing research projects and overseeing logistical requirements at various stages of drug development.
Title
Randal Eckert holds the title of Associate Director, Research Project Management at Bristol Myers Squibb. His role involves managing complex research initiatives, ensuring cross-functional collaboration, and maintaining project timelines and budgets.
Education and Expertise
Randal Eckert received his Doctor of Philosophy (Ph.D.) in Microbiology, Immunology, and Molecular Genetics from the University of California, Los Angeles, where he studied from 2001 to 2006. Prior to that, he earned a Bachelor of Science (BS) in Microbiology from Washington State University, studying from 1997 to 2001. His educational background provides a strong foundation in the scientific principles crucial to drug development.
Professional Background
Randal Eckert has extensive experience in the biotech and pharmaceutical industries. Before his current position, he worked at Silverback Therapeutics as Senior Director of Nonclinical Development from 2017 to 2019. He also served as Principal at Eckert BioConsulting from 2016 to 2020. Earlier in his career, he was Senior Director of Preclinical Biology at Armata Pharmaceuticals, Inc. from 2005 to 2017.
Achievements and Skills
Randal Eckert has developed cross-functional R&D strategies, managed vendor contracts, and led the establishment of functional area teams. He has set milestones and budgets for various research projects and has engaged in academic collaborations and federal grants. His effective communication skills have facilitated Board-level presentations and strategic partnerships. Additionally, as the first employee and founding member of a biotech startup, he gained expert interpersonal skills and witnessed the growth of the company to over 50 employees.